WithingsHybrid smartwatchEvidence-based assessment

Withings ScanWatch 2 review

Updated 2026-05-16

7.4
/ 10

A hybrid analog watch with medical-grade ECG and a ~30-day battery — strong on clinical health metrics, competent rather than class-leading as a dedicated HRV tracker.

Best for a discreet hybrid watch with clinical-grade health screening and no subscription.

The Withings ScanWatch 2 is the clinical-health pick here — a hybrid analog watch with a regulator-cleared single-lead ECG, SpO2, temperature and sleep-apnea detection, a roughly 30-day battery and no subscription. As a pure HRV tracker it is competent rather than class-leading.

How we tested: Evidence-based assessment — scored from manufacturer specifications, independent 2026 reviews and published validation literature. Not hands-on tested by ONDA.

Visit Withings official site →

[ SCORE_BREAKDOWN ]

HRV measurement accuracy

7.0

Overnight optical HRV plus an on-demand single-lead ECG — solid, though the continuous signal is optical, not electrical.

Sensor and signal quality

8.0

Optical PPG paired with a regulator-cleared single-lead ECG, SpO2 and a temperature sensor.

Sleep tracking accuracy

7.0

Competent sleep tracking with a sleep-quality score and breathing-disturbance (apnea) detection.

Data access and export

7.0

The Withings Health Mate app, with reasonable export and a developer API.

Wearability and battery

8.5

A roughly 30-day battery in a discreet hybrid analog watch — the easiest device here to simply wear and forget.

App and software experience

7.0

Health Mate is clean and clear, if less recovery-focused than Oura or Whoop.

Value

7.5

A one-time purchase around 350 USD, no subscription, with genuine clinical-grade features.

Pros

  • +Regulator-cleared single-lead ECG on the wrist
  • +A discreet hybrid analog design with a ~30-day battery
  • +No subscription — clinical features unlocked at purchase
  • +Sleep-apnea and SpO2 screening built in

Cons

  • Continuous HRV is optical, not electrical — not reference-grade
  • Less recovery-focused than Oura or Whoop
  • A small dial and no full touchscreen
  • HRV is a secondary metric, not the headline

Price: $350 one-time; no subscription (as of 2026-05-16)

Where it leads

The Withings ScanWatch 2 is the clinical-health pick of this comparison. It looks like an ordinary analog watch, but it carries a regulator-cleared single-lead ECG, SpO2, a temperature sensor and breathing-disturbance detection — and it runs for roughly a month on a charge. It is the easiest device here to simply wear and forget, and there is no subscription: the clinical features are unlocked at purchase.

Where it falls short

For dedicated HRV work it is competent rather than class-leading. The ECG is an on-demand spot reading, not a continuous protocol, so the all-night HRV signal is still optical — fine for trends, short of the reference-grade accuracy of a chest strap. It is also less recovery-focused than Oura or Whoop: HRV is one health metric among many here, not the headline.

Who it is for

Choose the Withings ScanWatch 2 if you want a discreet, long-lasting watch with genuine clinical screening — ECG, SpO2, apnea — and no subscription, and you treat HRV as one signal among several. If overnight HRV and recovery are the whole point, a dedicated ring or band will track them more closely.

References

  1. Withings ScanWatch 2 — official product page
  2. Wrist-worn ECG and HRV validation studies (PubMed)

Related reviews